Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
1.710
-0.070 (-3.93%)
At close: May 15, 2025, 4:00 PM
1.730
+0.020 (1.17%)
After-hours: May 15, 2025, 6:51 PM EDT
Sana Biotechnology Stock Forecast
SANA's stock price has decreased by -80.12% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Sana Biotechnology stock ranges from a low of $5.00 to a high of $15. The average analyst price target of $9.50 forecasts a 455.56% increase in the stock price over the next year.
Price Target: $9.50 (+455.56%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sana Biotechnology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +543.27% | Apr 24, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +192.40% | Mar 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +543.27% | Mar 18, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +309.36% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | +543.27% | Jan 8, 2025 |
Financial Forecast
Revenue This Year
n/a
from 94.93M
Revenue Next Year
n/a
EPS This Year
-0.91
from -1.16
EPS Next Year
-0.87
from -0.91
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.65 | -0.63 | -0.56 | ||
| Avg | -0.91 | -0.87 | -0.85 | ||
| Low | -1.12 | -1.09 | -0.95 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.